90 related articles for article (PubMed ID: 15605596)
41. Quality by design approach for formulation development: a case study of dispersible tablets.
Charoo NA; Shamsher AA; Zidan AS; Rahman Z
Int J Pharm; 2012 Feb; 423(2):167-78. PubMed ID: 22209997
[TBL] [Abstract][Full Text] [Related]
42. Influence of Eudragit NE 30 D blended with Eudragit L 30 D-55 on the release of phenylpropanolamine hydrochloride from coated pellets.
Zheng W; McGinity JW
Drug Dev Ind Pharm; 2003 Mar; 29(3):357-66. PubMed ID: 12741617
[TBL] [Abstract][Full Text] [Related]
43. Novel combination of anionic and cationic polymethacrylate polymers for sustained release tablet preparation.
Obeidat WM; Abu Znait AH; Sallam AS
Drug Dev Ind Pharm; 2008 Jun; 34(6):650-60. PubMed ID: 18568916
[TBL] [Abstract][Full Text] [Related]
44. Effects of metal ions on entero-soluble poly(methacrylic acid-methyl methacrylate) coating: a combined analysis by ATR-FTIR spectroscopy and computational approaches.
Cilurzo F; Gennari CG; Selmin F; Vistoli G
Mol Pharm; 2010 Apr; 7(2):421-30. PubMed ID: 20052997
[TBL] [Abstract][Full Text] [Related]
45. Preparation and characterization of controlled release matrices based on novel seaweed interpolyelectrolyte complexes.
Prado HJ; Matulewicz MC; Bonelli PR; Cukierman AL
Int J Pharm; 2012 Jun; 429(1-2):12-21. PubMed ID: 22433798
[TBL] [Abstract][Full Text] [Related]
46. Kinetic parameters for thermal decomposition of supramolecular polymers derived from diclofenac-meglumine supramolecular adducts.
Cassimiro DL; Ferreira LM; Capela JM; Crespi MS; Ribeiro CA
J Pharm Biomed Anal; 2013 Jan; 73():24-8. PubMed ID: 22561058
[TBL] [Abstract][Full Text] [Related]
47. Eudragit RL-based film coatings: How to minimize sticking and adjust drug release using MAS.
Rongthong T; Sungthongjeen S; Siepmann F; Siepmann J; Pongjanyakul T
Eur J Pharm Biopharm; 2020 Mar; 148():126-133. PubMed ID: 31982576
[TBL] [Abstract][Full Text] [Related]
48. The influence of particles of a minor component on the matrix strength of sodium chloride.
van Veen B; van der Voort Maarschalk K; Bolhuis GK; Gons M; Zuurman K; Frijlink HW
Eur J Pharm Sci; 2002 Sep; 16(4-5):229-35. PubMed ID: 12208452
[TBL] [Abstract][Full Text] [Related]
49. Drug release from methyl acrylate-methyl methacrylate copolymer matrix III: stimultaneous release of noninteracting drug-excipient mixtures.
Farhadieh B
J Pharm Sci; 1976 Sep; 65(9):1333-7. PubMed ID: 966148
[TBL] [Abstract][Full Text] [Related]
50. Interaction of two diclofenac acid salts with copolymers of ammoniomethacrylate: effect of additives and release profiles.
Khalil E; Sallam A
Drug Dev Ind Pharm; 1999 Apr; 25(4):419-27. PubMed ID: 10194596
[TBL] [Abstract][Full Text] [Related]
51. The role of fillers and sodium metabisulfite on drug release from aged polyox tablets.
Shojaee S; Nokhodchi A; Cumming I
Drug Dev Ind Pharm; 2014 Nov; 40(11):1451-8. PubMed ID: 23962147
[TBL] [Abstract][Full Text] [Related]
52. Preparation and pharmaceutical evaluation of acetaminophen nano-fiber tablets: Application of a solvent-based electrospinning method for tableting.
Hamori M; Nagano K; Kakimoto S; Naruhashi K; Kiriyama A; Nishimura A; Shibata N
Biomed Pharmacother; 2016 Mar; 78():14-22. PubMed ID: 26898420
[TBL] [Abstract][Full Text] [Related]
53. Effects of a diluent on the retarded-release property of acrylate methacrylate--salicylic acid coacervates.
Okor RS; Yahaya MA
Pharm Res; 1990 Nov; 7(11):1208-9. PubMed ID: 2293223
[No Abstract] [Full Text] [Related]
54. Matrix formation in sustained release tablets: possible mechanism of dose dumping.
Krajacic A; Tucker IG
Int J Pharm; 2003 Jan; 251(1-2):67-78. PubMed ID: 12527176
[TBL] [Abstract][Full Text] [Related]
55. Microencapsulation of drugs by the coacervation technique using ethylcellulose and acrylate-methacrylate copolymer as wall materials.
Nimmannit U; Suwanpatra N
J Microencapsul; 1996; 13(6):643-9. PubMed ID: 8933350
[TBL] [Abstract][Full Text] [Related]
56. Development of sustained release matrix tablets of didanosine containing methacrylic and ethylcellulose polymers.
Sánchez-Lafuente C; Teresa Faucci M; Fernández-Arévalo M; Alvarez-Fuentes J; Rabasco AM; Mura P
Int J Pharm; 2002 Mar; 234(1-2):213-21. PubMed ID: 11839452
[TBL] [Abstract][Full Text] [Related]
57. Effects of compaction variables on porosity and material tensile strength of convex-faced aspirin tablets.
Pitt KG; Newton JM; Stanley P
J Pharm Pharmacol; 1991 Apr; 43(4):219-25. PubMed ID: 1676731
[TBL] [Abstract][Full Text] [Related]
58. Tablet and capsule hydrophilic matrices based on heterodisperse polysaccharides having porosity-independent in vitro release profiles.
Kelly ML; Tobyn MJ; Staniforth JN
Pharm Dev Technol; 2000; 5(1):59-66. PubMed ID: 10669919
[TBL] [Abstract][Full Text] [Related]
59. Synthesis, characterization, and in vitro drug release study of methacrylate diclofenac conjugate as macromolecular prodrug.
Agrawal N; Chandrasekar MJ; Sara UV; Rohini A
PDA J Pharm Sci Technol; 2010; 64(4):348-55. PubMed ID: 21502035
[TBL] [Abstract][Full Text] [Related]
60. Effect of polacrilin potassium as disintegrant on bioavailability of diclofenac potassium in tablets : a technical note.
Bele MH; Derle DV
AAPS PharmSciTech; 2012 Sep; 13(3):756-9. PubMed ID: 22585376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
